The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

FBT Attorneys-at-Law

RUE DU 31-DÉCEMBRE 47, CASE POSTALE 6120, 1211 GENEVA 6, SWITZERLAND
Tel:
Work +41 22 849 6040
Email:
Web:
www.fbt.ch
Geneva, Paris

Switzerland

Banking and finance: Geneva
Banking and finance: Geneva - ranked: tier 2

FBT Attorneys-at-Law

FBT Attorneys-at-Law has expertise in banking, finance regulations, fund investment, asset management and securities, while also representing clients in FINMA enforcement, civil and criminal proceedings. Frédérique Bensahel assisted a Swiss bank with the constitution and private placement of a private equity fund in relation to an international real estate project. Pierre-Olivier Etique and Jean-Louis Tsimaratos advised a fund asset manager on offering shares from two investment funds on a US-based electronic platform.

Leading individuals

Frédérique Bensahel - FBT Attorneys-at-Law

Next generation lawyers

Pierre-Olivier Etique - FBT Attorneys-at-Law

[back to top]

Commercial, corporate and M&A
Commercial, corporate and M&A - ranked: tier 4

FBT Attorneys-at-Law

FBT Attorneys-at-Law is active in the French-speaking part of Switzerland, with key areas including international M&A transactions and commercial contracts advice. The team further assists with mergers, as well as investment, lease and distribution agreements. Marco Villa has experience in real estate and banking-related deals.

[back to top]

Dispute resolution: litigation
Dispute resolution: litigation - ranked: tier 4

FBT Attorneys-at-Law

FBT Attorneys-at-Law is best known for its experience in Swiss and international banking litigation, while also covering the commercial, insolvency, employment, insurance, real estate and criminal practice areas. In a new highlight, Michael Biot represents several investors in their civil and criminal claims concerning the alleged Ponzi scheme of an asset management company. Serge Fasel continues to act for a Swiss bank in the recovery of amounts paid as taxes on the assets of British customers.

[back to top]

Leading firms: French-speaking Switzerland
Leading firms: French-speaking Switzerland - ranked: tier 3

FBT Attorneys-at-Law

'Dynamic and well-reputed firm' FBT Attorneys-at-Law has 'a pragmatic approach to problems and considerable experience in regulatory and financial environments'. Based in Geneva, the team handles banking, corporate and commercial, private client, tax and litigation work. Frédérique Bensahel, Jean-Louis Tsimaratos and Pierre-Olivier Etique are active in banking and finance, while tax partner Jean-Luc Bochatay, private client specialist Michel Abt and corporate lawyer Marco Villa are other key practitioners.

[back to top]

Private client
Private client - ranked: tier 3

FBT Attorneys-at-Law

FBT Attorneys-at-Law's client base comprises high-net-worth individuals and family offices, as well as intermediaries such as banks, wealth managers, investment funds and fund asset managers. The practice acts for clients in private banking, international succession, fund, trust structuring, tax, transactions and relocation matters. Department lead Frédérique Bensahel, tax partners Jean-Luc Bochatay and Michel Abt, as well as banking specialist Jean-Louis Tsimaratos make up the core team.

[back to top]

Tax
Tax - ranked: tier 3

FBT Attorneys-at-Law

'One of the top experts in Swiss and French tax law', FBT Attorneys-at-Law impresses with its 'excellent level of competency, tailored advice and great interpersonal skills'. Areas of strength include administrative assistance with tax matters and procedures, wealth and estate planning, advising on the tax aspects of relocation from or to Switzerland and expatriation, as well as corporate, financial and real estate taxation. Michel Abt and Jean-Luc Bochatay are the practice heads.

[back to top]


Further information on FBT Attorneys-at-Law

Please choose from this list to view details of what we say about FBT Attorneys-at-Law in other jurisdictions.

Switzerland

Offices in Geneva

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Ordinance on Integrity and Transparency in the Therapeutic Products Sector has been adopted

    Click here for more information.
  • Bär & Karrer Advises B3i in its Current Equity Funding Round

    Industry-led InsurTech B3i Services AG successfully raised additional funds from current shareholders and new investors to further develop and grow its blockchain-based insurance transaction platform. B3i was founded in October 2016 as an insurance industry consortium which then formed B3i Services AG as an independent company. The shareholder group includes some of the world's largest insurers and reinsurers from across Europe, the Americas, and Asia. B3i intends to further expand its shareholder base over the next several months.
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from ElĂ©t

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.
  • Bär & Karrer Advises Addtech in the Acquisition of a Majority in Omni Ray

    Addtech Group, a leading Swedish publicly listed technology trading group, acquired a majority stake in Omni Ray AG, a well-established Swiss trading company and service provider for automation solutions, mainly focused on industrial applications, infrastructure, transportation and medical industry. By this transaction, Addtech aims at strengthening its position in the European automation market.